Progress in the pathophysiology of diabetes retinopathy

doi:10.3969/j.issn.1006-7795.2023.03.010

Abstract

Abstract: Diabetic retinopathy (DR), one of the important causes of blindness in adults, seriously threatens the life quality of patients with diabetes mellitus and brings heavy economic burden to the society. Previous studies have shown that the impairment of neurovascular unit (NVU) plays an important role in the occurrence and development of DR, including retinal vascular endothelial cells damage, impairment of cell junctions, loss of pericytes, pericyte-endothelial cells communication impairment and so on.

Key words: diabetes mellitus, diabetic retinopathy, neurovascular unit

CLC Number:

Feng Xiaotong, Ke Jing, Zhu Lin, Zhao Dong. Progress in the pathophysiology of diabetes retinopathy[J]. Journal of Capital Medical University, 2023, 44(3): 420-423.

0
/ / Recommend

Add to citation manager EndNote|Reference Manager|ProCite|BibTeX|RefWorks

URL: https://journal03.magtech.org.cn/Jweb_sdykdxxb/EN/10.3969/j.issn.1006-7795.2023.03.010

https://journal03.magtech.org.cn/Jweb_sdykdxxb/EN/Y2023/V44/I3/420

References

［1］Hou Y Y, Cai Y T, Jia Z M, et al. Risk factors and prevalence of diabetic retinopathy: a protocol for meta-analysis［J］. Medicine (Baltimore), 2020, 99(42): e22695.
［2］Chua J, Lim C X Y, Wong T Y, et al. Diabetic retinopathy in the Asia-Pacific［J］. Asia Pac J Ophthalmol (Phila), 2018, 7(1): 3－16.
［3］Cheung N, Mitchell P, Wong T Y. Diabetic retinopathy［J］. Lancet, 2010, 376(9735): 124－136.
［4］Solomon S D, Chew E, Duh E J, et al. Diabetic retinopathy: a position statement by the American diabetes association［J］. Diabetes Care, 2017, 40(3): 412－418.
［5］Antonetti D A, Silva P S, Stitt A W. Current understanding of the molecular and cellular pathology of diabetic retinopathy［J］. Nat Rev Endocrinol, 2021, 17(4): 195－206.
［6］Simó R, Stitt A W, Gardner T W. Neurodegeneration in diabetic retinopathy: does it really matter?［J］. Diabetologia, 2018, 61(9): 1902－1912.
［7］Klaassen I, Van Noorden C J F, Schlingemann R O. Molecular basis of the inner blood-retinal barrier and its breakdown in diabetic macular edema and other pathological conditions［J］. Prog Retin Eye Res, 2013, 34: 19－48.
［8］Brownlee M. The pathobiology of diabetic complications: a unifying mechanism［J］. Diabetes, 2005, 54(6): 1615－1625.
［9］Uribarri J, Stirban A, Sander D, et al. Single oral challenge by advanced glycation end products acutely impairs endothelial function in diabetic and nondiabetic subjects［J］. Diabetes Care, 2007, 30(10): 2579－2582.
［10］Limb G A, Hickman-Casey J, Hollifield R D, et al. Vascular adhesion molecules in vitreous from eyes with proliferative diabetic retinopathy［J］. Invest Ophthalmol Vis Sci, 1999, 40(10): 2453－2457.
［11］Mizutani M, Kern T S, Lorenzi M. Accelerated death of retinal microvascular cells in human and experimental diabetic retinopathy［J］. J Clin Invest, 1996, 97(12): 2883－2890.
［12］Wei L F, Mo W W, Lan S S, et al. GLP-1 RA improves diabetic retinopathy by protecting the blood-retinal barrier through GLP-1R-ROCK-p-MLC signaling pathway［J］. J Diabetes Res, 2022, 2022: 1861940.
［13］Ting K K, Zhao Y, Shen W Y, et al. Therapeutic regulation of VE-cadherin with a novel oligonucleotide drug for diabetic eye complications using retinopathy mouse models［J］. Diabetologia, 2019, 62(2): 322－334.
［14］Trost A, Lange S, Schroedl F, et al. Brain and retinal pericytes: origin, function and role［J］. Front Cell Neurosci, 2016, 10: 20.
［15］Ogura S, Kurata K, Hattori Y, et al. Sustained inflammation after pericyte depletion induces irreversible blood-retina barrier breakdown［J］. JCI Insight, 2017, 2(3): e90905.
［16］Eshaq R S, Aldalati A M Z, Alexander J S, et al. Diabetic retinopathy: breaking the barrier［J］. Pathophysiology, 2017, 24(4): 229－241.
［17］Eleftheriou C G, Ivanova E, Sagdullaev B T. Of neurons and pericytes: the neuro-vascular approach to diabetic retinopathy［J］. Vis Neurosci, 2020, 37: E005.
［18］Hammes H P, Feng Y X, Pfister F, et al. Diabetic retinopathy: targeting vasoregression［J］. Diabetes, 2011, 60(1): 9－16.
［19］Ivanova E, Kovacs-Oller T, Sagdullaev B T. Vascular pericyte impairment and connexin43 gap junction deficit contribute to vasomotor decline in diabetic retinopathy［J］. J Neurosci, 2017, 37(32): 7580－7594.
［20］Pfister F, Feng Y, Vom Hagen F, et al. Pericyte migration: a novel mechanism of pericyte loss in experimental diabetic retinopathy［J］. Diabetes, 2008, 57(9): 2495－2502.
［21］Huang H. Pericyte-endothelial interactions in the retinal microvasculature［J］. Int J Mol Sci, 2020, 21(19): 7413.
［22］Middel C S, Hammes H P, Kroll J. Advancing diabetic retinopathy research: analysis of the neurovascular unit in zebrafish［J］. Cells, 2021, 10(6): 1313.
［23］Eilken H M, Diéguez-Hurtado R, Schmidt I, et al. Pericytes regulate VEGF-induced endothelial sprouting through VEGFR1［J］. Nat Commun, 2017, 8(1): 1574.
［24］Hammes H P. Diabetic retinopathy: hyperglycaemia, oxidative stress and beyond［J］. Diabetologia, 2018, 61(1): 29－38.
［25］Nian S, Lo A C Y, Mi Y J, et al. Neurovascular unit in diabetic retinopathy: pathophysiological roles and potential therapeutical targets［J］. Eye Vis (Lond), 2021, 8(1): 15.
［26］Kinuthia U M, Wolf A, Langmann T. Microglia and inflammatory responses in diabetic retinopathy［J］. Front Immunol, 2020, 11: 564077.
［27］Mugisho O O, Rupenthal I D, Squirrell D M, et al. Intravitreal pro-inflammatory cytokines in non-obese diabetic mice: modelling signs of diabetic retinopathy［J］. PLoS One, 2018, 13(8): e0202156.

[1]	Li Yuyang, Zhu Xiaorong, Liu Jing, Zheng Xiaomin, Yang Jinkui, Yang Fangyuan. Analysis of haptoglobin gene polymorphisms and serum haptoglobin levels in patients with diabetes kidney disease [J]. Journal of Capital Medical University, 2023, 44(3): 375-380.
[2]	Zheng Xiaomin, Li Bin, Liu Cuiping, Zhou Yingsheng, Cui Limei. Analysis and treatment of dawn phenomenon in elderly patients with type 2 diabetes mellitus [J]. Journal of Capital Medical University, 2023, 44(3): 400-406.
[3]	Li Mingjia, Zhao Miaomiao , Yang Jinkui . Research progress of cathepsin in the mechanism of diabetes and diabetic nephropathy [J]. Journal of Capital Medical University, 2023, 44(3): 413-419.
[4]	Xia Ning, Nie Xiuhong, Wang Meiping, Feng Zhihong, Mu Zhijing, Fan Xiaojun. Association between sleep efficiency and diabetes mellitus in obstructive sleep apnea syndrome and primary snoring patients [J]. Journal of Capital Medical University, 2023, 44(3): 487-496.
[5]	Ma Yuru, Yuan Xianxian, Zheng Wei, Liu Cheng, Wang Jia, Li Guanghui. Certain serum free fatty acids during the first trimester of pregnancy associated with gestational diabetes mellitus [J]. Journal of Capital Medical University, 2023, 44(2): 265-271.